Sima Solaimanzadeh
Physical Medicine & Rehabilitation · South Plainfield, NJNPI 1629203401
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 750 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by AbbVie at 28.4% of the total. Among physical medicine & rehabilitation clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 750 payments — averaging $12.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Teva Pharmaceuticals USA, Inc.$844
- Lilly USA, LLC$811
- Pfizer$596
- Amgen$528
- Novo Nordisk$440
- plus $3K from 29 others
What the payments were for
- Food & beverage$9,19199%
- Education$1251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 241 | $2,644 |
| Teva Pharmaceuticals USA, Inc. | 60 | $844 |
| Lilly USA, LLC | 55 | $811 |
| Pfizer | 43 | $596 |
| Amgen(2 entities) | 35 | $528 |
| Novo Nordisk | 49 | $440 |
| Lundbeck LLC | 27 | $382 |
| Upsher-smith Laboratories LLC | 27 | $353 |
| Currax Pharmaceuticals LLC | 28 | $343 |
| Impel Pharmaceuticals Inc. | 26 | $316 |
| Biohaven Pharmaceuticals, Inc. | 18 | $249 |
| Novartis | 16 | $245 |
| Supernus Pharmaceuticals, Inc. | 22 | $243 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $241 |
| Biohaven Pharmaceutical Holding Company Ltd. | 20 | $228 |
| Zyla Life Sciences, Inc. | 27 | $205 |
| Tonix Medicines, Inc. | 6 | $108 |
| Assertio Therapeutics, Inc. | 6 | $81 |
| Abbott | 3 | $72 |
| Promius Pharma LLC | 4 | $57 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| AstraZeneca(2 entities) | 2 | $35 |
| Alkermes, Inc. | 2 | $32 |
| Impel Pharmaceuticals LLC | 3 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Bausch Health US, LLC | 2 | $27 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Biotronik Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $13 |
| Indivior Inc. | 1 | $13 |
| Seqirus USA Inc | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
How this compares
$9,315 in reported general payments places this provider in the 95th percentile of 434 physical medicine & rehabilitation providers in New Jersey.
See all physical medicine & rehabilitation providers in New Jersey →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dihydroergotamine Mesylate | 15 | $29,889 |
| ZavzpretZavegepant Hcl | 12 | $18,200 |
| QuliptaAtogepant | 12 | $12,328 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $8,571 |
| Sumatriptan Succinate | 16 | $106 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerZavzpret | $596 | $18,20012 claims |
| AbbVieQulipta | $2,644 | $12,32812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 434 physical medicine & rehabilitation providers in New Jersey.
Other physical medicine & rehabilitation in South Plainfield
- Steven EscaldiEdison$70K
- Yekyung KongWest Orange$61K
- Joseph IbrahimBayonne$50K
- Steven KirshblumWest Orange$47K
- Joseph ValenzaChester$29K
- Christine GreissEdison$28K
- Bianca MartinezManasquan$25K
- Jason SmithCedar Knolls$19K
- Sandeep RathiLakewood$14K
- Anand PooleriCamden$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.